HOW AND WHERE TO BUY LOMEFLOXACIN (MAXAQUIN) 400 MG TABLETS OR CAPSULES ONLINE:
from $1.70 per pill
5% discount coupon: dmeds5
from $1.97 per pill
10% discount coupon: hf-5478
CHEAP MEDS FOR SALE
from $2.36 per pill
5% discount coupon: 5OFF
MAXAQUIN (LOMEFLOXACIN HYDROCHLORIDE) TABLETS: DRUG INTERACTIONS
In three pharmacokinetic studies including 46 normal, healthy subjects, theophylline clearance and concentration were not significantly altered by the addition of lomefloxacin. In clinical studies where patients were on chronic theophylline therapy, lomefloxacin had no measurable effect on the mean distribution of theophylline concentrations or the mean estimates of theophylline clearance. Though individual theophylline levels fluctuated, there were no clinically significant symptoms of drug interaction.
Antacids and Sucralfate
Sucralfate and antacids containing magnesium or aluminum, as well as formulations containing divalent and trivalent cations such as Videx (Didanosine), chewable/buffered tablets or the pediatric powder for oral
solution can form chelation complexes with Lomefloxacin Hydrochloride (Maxaquin) and interfere with its bioavailability. Sucralfate administered 2 hours before lomefloxacin resulted in a slower absorption (mean Cmax decreased by 30% and mean Tmax increased by 1 hour) and a lesser extent of absorption (mean AUC decreased by approximately 25%). Magnesium- and aluminum-containing antacids, administered concomitantly with lomefloxacin, significantly decreased the bioavailability (48%) of lomefloxacin. Separating the doses of antacid and lomefloxacin minimizes this decrease in bioavailability; therefore, administration of these agents should precede lomefloxacin
dosing by 4 hours or follow lomefloxacin dosing by at least 2 hours.
Two hundred mg of caffeine (equivalent to 1 to 3 cups of American coffee) was administered to 16 normal, healthy volunteers who had achieved steady-state blood concentrations of lomefloxacin after being dosed at 400 mg qd. This did not result in any statistically or clinically relevant changes in the pharmacokinetic parameters of either caffeine or its major metabolite, paraxanthine. No data are available on potential interactions in individuals who consume greater than 200 mg of caffeine per day or in those, such as the geriatric population, who are generally believed to be more susceptible to the development of drug-induced CNS-related adverse effects. Other quinolones have demonstrated moderate to marked interference with the metabolism of caffeine, resulting in a reduced clearance, a prolongation of plasma half-life, and an increase in symptoms that accompany high levels of caffeine.
Cimetidine has been demonstrated to interfere with the elimination of other quinolones. This interference has resulted in significant increases in half-life and AUC. The interaction between lomefloxacin and cimetidine has not been studied.
Elevated serum levels of cyclosporine have been reported with concomitant use of cyclosporine with other members of the quinolone class. Interaction between Lomefloxacin (Maxaquin) tablets and cyclosporine has not been studied.
No clinically significant changes in lomefloxacin pharmacokinetics (AUC, Cmax, or Tmax) were observed when a single dose of lomefloxacin 400 mg was given after multiple doses of omeprazole (20 mg qd) in 13 healthy volunteers. Changes in omeprazole pharmacokinetics were not studied.
No significant differences were observed in mean phenytoin AUC, Cmax, Cmin or Tmax (although Cmax increased by 11%) when extended phenytoin sodium capsules (100 mg tid) were coadministered with lomefloxacin (400 mg qd) for five days in 15 healthy males. Lomefloxacin is unlikely to have a significant effect on phenytoin metabolism.
Probenecid slows the renal elimination of lomefloxacin. An increase of 63% in the mean AUC and increases of 50% and 4%, respectively, in the mean Tmax and mean Cmax were noted in 1 study of 6 individuals.
No clinically significant changes occurred in heart rate or corrected QT intervals, or in terfenadine metabolite or Lomefloxacin HCl (Maxaquin) tablets pharmacokinetics, during concurrent administration of lomefloxacin and terfenadine at steady-state in 28 healthy males.
Quinolones may enhance the effects of the oral anticoagulant, warfarin, or its derivatives. When these products are administered concomitantly, prothrombin or other suitable coagulation tests should be monitored closely. However, no clinically or statistically significant differences in prothrombin time ratio or warfarin enantiomer pharmacokinetics were observed in a small study of 7 healthy males who received both warfarin and lomefloxacin under steady-state conditions.
Maxaquin (Lomefloxacin Hydrochloride) tablets related pharmaceutical drugs and medications
|Trade name of the drug
||Pharmaceutical forms and doses
||Capsules; Oral; Fluconazole 50 mgCapsules; Oral; Fluconazole 100 mgCapsules; Oral; Fluconazole 150 mgCapsules; Oral; Fluconazole 200 mg
||Capsules; Oral; Cefixime 200 mgCapsules; Oral; Cefixime 400 mgSuspension; Oral; Cefixime 100 mg / 5 mlSuspension; Oral; Cefixime 200 mg / 5 ml
||Drops; Otic; Hydrocortisone 1%
|Betnovate-GM drug interactions
||Cream; Topical; Betamethasone Valerate 0.12%; Gentamicin Sulfate 0.1%; Miconazole Nitrate 2%
||Powder for Suspension; Oral; Amoxicillin Trihydrate 125 mg; Clavulanate Potassium 31.25 mg / 5 mlPowder for Suspension; Oral; Amoxicillin Trihydrate 250 mg; Clavulanate Potassium 62.5 mg / 5 mlTablets, Film-Coated; Oral; Amoxicillin Trihydrate 500 mg; Clavulanate Potassium 125 mgTablets, Film-Coated; Oral; Amoxicillin Trihydrate 875 mg; Clavulanate Potassium 125 mg
||G.L. PharmaLannacher Heilmittel
|Plaquenil drug interactions
||Tablets, Film-Coated; Oral; Hydroxychloroquine Sulfate 200 mg
Order Maxaquin (Lomefloxacin) Online
Maxaquin prescribing information
Copyright © Lomefloxacin.meddrugs.org